Arkolith/Insider Trading/RAPP/Form 4

Bredt David

Chief Scientific OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Nov 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$214K
Net Open-Market Flow
-$214K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Sell(S)5K$25.39$136K401K
Nov 17, 2025Sell(S)3K$24.84$78K406K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-286212) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML